PUBLISHER: Grand View Research | PRODUCT CODE: 1842033
PUBLISHER: Grand View Research | PRODUCT CODE: 1842033
The Europe equine healthcare market size was estimated at USD 1.00 billion in 2024 and is projected to reach USD 1.90 billion by 2033, growing at a CAGR of 7.57% from 2025 to 2033. The market is witnessing growth driven by the growing equine population and economic value, rising veterinarian guidance for preventive care, and increasing adoption of insurance and welfare programs.
The growing equine population within countries such as Germany, France, and the UK is creating opportunities for advanced veterinary care for the development of pharmaceuticals, vaccines, diagnostics, or services. According to the European Commission report, the equine population in the European Union (EU) is estimated to be approximately 6 million, with 429,800 horses in the UK. This rising equine population is driving significant growth opportunities in Europe's equine healthcare market, fostering innovation across pharmaceuticals, vaccines, diagnostics, and veterinary services.
Some of the countries in Europe, such as the UK, France, and Ireland, are continuously involved in horse breeding and recreational or sports activities. Hence, horses are of great economic value in the category of companion animals. Their high economic importance drives the market for larger investment in veterinary care, advanced therapeutics, and specialized hospital services. For instance, in March 2024, Scandinavian ChemoTech's Animal Care secured a USD 52k order from Europe's leading equine clinic, EquiTom (Belgium), adopting vetIQure TSE technology after successful sarcoid treatments, enhancing innovation and patient outcomes in equine healthcare. As a result, the need for efficient healthcare solutions, including pharmaceuticals, vaccines, diagnostic tools, and reproductive management products, continues to expand across European equine markets.
Rising veterinarian guidance for preventive care is one of the drivers of the European equine healthcare market. With increasing awareness of equine welfare, veterinarians are emphasizing regular check-ups, vaccinations, deworming, and nutritional management to reduce the incidence of costly diseases. Preventive protocols help owners maintain peak equine performance, minimize risks of infectious outbreaks, and improve long-term health outcomes. In Europe, structured veterinary programs and educational campaigns encourage horse owners to adopt proactive healthcare measures rather than reactive treatment. For instance, in November 2022, British Equestrian launched Equine Health Week with vet-led education, daily disease awareness and the release of new EIDAG (Equine Infectious Diseases Advisory Group) guidance to reduce equine infectious disease risks. In addition, in March 2023, CANTER, launched to combat equine antiparasitic resistance, uniting veterinarians, pharmaceutical companies, diagnostic providers, and policymakers to promote sustainable parasite control and safeguard horse health and welfare. This shift enhances animal well-being and fuels demand for vaccines, supplements, and diagnostic services, boosting the industry.
Europe Equine Healthcare Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Europe equine healthcare market report based on product, indication, activity, distribution channel, and country: